Agios Pharma's stock soars 19.6% on news of positive results in trial of treatment for rare blood disorder
Agios Pharmaceuticals Inc.’s stock soared 19.6% early Wednesday, after the biotech announced positive results from a Phase 3 trial of a treatment for a rare...